Antibiotics for pneumonia include Zithromax (azithromycin), Biaxin (clarithromycin), and Erythrocin (erythromycin). Azithromycin is often the first-line treatment since it is effective against many ...

Antibiotic therapy with extended anaerobic coverage (EAC) was not associated with a survival benefit in patients with community-acquired aspiration pneumonia, according to results from a retrospective ...

A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk. C. diff infections can be deadly, and ...

The authors sought to assess the effectiveness of short vs prolonged-course antibiotic administration for hospital-acquired pneumonia in critically ill adults (most of whom had VAP) by conducting a ...

In our current health care environment, hospitals and health care providers are challenged to provide a high standard of care in a more efficient way. Multiple evidence-based practice guidelines ...

The Food and Drug Administration on Tuesday approved a combination drug for treating patients with bacterial pneumonia caused by the highly antibiotic resistant Acinetobacter baumannii-calcoaceticus ...

Less is also better – that is what researchers have found while conducting a tri-nation clinical trial to see if shorter courses of antibiotics are as effective as longer prescriptions of the drug to ...

Pneumonia, shown in this x-ray image, accounts for more than 1 million hospitalizations in the U.S. annually. New scientific evidence suggests that doctors should reconsider using drugs that target ...

Please provide your email address to receive an email when new articles are posted on . More than 20% of children diagnosed with pneumonia did not receive antibiotics. Treatment failure was slightly ...

Inappropriate use of broad-spectrum antibiotics to treat children with pneumonia remains common, despite guidelines recommending more targeted treatment, two studies published online March 7 in ...

Pneumococcal disease leads to over three million hospitalizations and hundreds of thousands of deaths annually. A new study suggests that the FDA-approved drug Fomepizole may reduce disease severity ...